Treatment
This study consists of two different treatment options:
Trastuzumab Deruxtecan + bevacizumab
Bevacizumab
The treatment is given every 3 weeks as first-line maintenance therapy.
Treatment duration
Up to 16 cycles of maintenance therapy is allowed.
Contact
To be able to give you the best information and care we do not give medical advice via mail. We kindly ask you to make an appointment via lgog@uzleuven.be.